Clarivate (NYSE:CLVT) Releases FY25 Earnings Guidance

Clarivate (NYSE:CLVT) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.60-$0.70 for the period, compared to the consensus EPS estimate of $0.73. The company issued revenue guidance of $2.28-$2.40 billion, compared to the consensus revenue estimate of $2.53 billion. Clarivate also updated its FY 2025 guidance to 0.600-0.700 EPS.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Royal Bank of Canada decreased their target price on shares of Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a report on Thursday, November 7th. William Blair cut shares of Clarivate from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 6th. Finally, Barclays cut their target price on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating for the company in a research report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $7.10.

Clarivate Price Performance

NYSE CLVT traded down $0.08 on Wednesday, reaching $4.76. 20,544,830 shares of the company’s stock traded hands, compared to its average volume of 5,205,901. The stock has a market cap of $3.38 billion, a PE ratio of -2.39 and a beta of 1.17. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.88 and a quick ratio of 0.88. Clarivate has a 12 month low of $4.22 and a 12 month high of $9.07. The stock has a 50-day simple moving average of $5.15 and a 200 day simple moving average of $5.82.

Clarivate declared that its Board of Directors has approved a share repurchase program on Monday, December 16th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 12.8% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling

In related news, Director Michael J. Angelakis purchased 765,000 shares of Clarivate stock in a transaction that occurred on Friday, November 22nd. The shares were acquired at an average cost of $5.19 per share, for a total transaction of $3,970,350.00. Following the transaction, the director now directly owns 3,465,000 shares in the company, valued at $17,983,350. The trade was a 28.33 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 23.14% of the stock is owned by corporate insiders.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.